Specialisation
Cornea
Full title
A Double-Masked, Randomised, Placebo-Controlled, Parallel-Group, 12-Week, Phase 2 Study to Investigate the Safety and Efficacy of Ripasudil (K-321) Eye Drops After Descematorhexis in Patients with Fuchs Endothelial Corneal Dystrophy
Promoter
Kowa Research Institute, Inc
Start date
July 2020
Researchers
Main: Dr José Luis Güell
Co-Researchers: Dr Gris, Dr Barbany